While earlier use of thiazolidinediones may be advantageous, the longerterm picture requires clarification.
Estimates of insulin sensitivity and beta-cell function (based on analysis of fasting glucose and insulin concentrations) have indicated that both defects can be improved by the addition of a thiazolidinedione.
The effects on plasma lipids and apoproteins have been the subject of debate.